Skip to main content

Table 6 Statements reaching consensus regarding themes 3 and 4

From: Cancer related fatigue: implementing guidelines for optimal management

Theme 3: Integrate CRF management with existing practices

Survey

N

Agree (n)

Agree (%)

 Fatigue management should be a part of routine cancer services

C2

59

57

96.6

 Once clinicians identify moderate to severe fatigue they should seek advice and/or refer for comprehensive assessment

HP2

32

31

96.9

 Ask me about my fatigue level during routine appointments

C2

59

48

81.4

 A self-assessment for patient to identify issues would be time-efficient for clinicians

HP2

32

26

81.3

 Applying standardised diagnostic criteria for CRF is useful in the clinical setting to distinguish CRF from other types of fatigue

HP2

32

26

81.3

Theme 4: Consumer-focused care

Survey

N

Agree (n)

Agree (%)

 Essential time points for fatigue screening

    

  At diagnosis

HP2

32

24

75.0

  At diagnosis or start of treatment as baseline

C2

59

48

81.4

  At end of a treatment course

C2

59

52

88.1

  During routine assessment before each new treatment

C2

59

52

88.1

  After hospitalisation or changed health status

C2

59

51

86.4

  3 months post treatment

C2

59

50

84.7

  At annual check up

C2

59

48

81.4

 It is essential to be made aware of the possibility of fatigue and how to measure it, when you are first diagnosed with cancer

C2

59

53

89.8

 Information and education about fatigue should be offered at different levels of detail (e.g. basic, standard, detailed)

C2

59

53

89.8

 Access to individual or group education about fatigue supported by written material is important to me

C2

59

53

89.8

 It is important to me to have some say in when, where and how I am assessed if I have moderate to severe fatigue

C2

59

52

89.8

 I would like to be given the choice of doing a paper, electronic or verbal questionnaire to assess my fatigue

C2

59

50

88.8

 I would prefer a longer appointment for fatigue assessment compared to extra visits

C2

59

46

78.0

 More detailed information about fatigue prevention can come once treatment has started.

C2

59

45

76.2

 One of the five most important factors that would encourage you (CS) to adopt the CAPO guideline: If my health professional promoted its use

C1

32

24

75.0